Overview
Miguel Cordero-Sampayo practices in Barcelona, Spain. Mr. Cordero-Sampayo is rated as an Advanced expert by MediFind in the treatment of Mucopolysaccharidoses (MPS). His top areas of expertise are Breast Cancer, Mucopolysaccharidoses (MPS), Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), and HER-2 Positive Breast Cancer.
His clinical research consists of co-authoring 39 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Mucopolysaccharidoses (MPS).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerMr. Cordero-Sampayo isAdvanced. Learn about Breast Cancer.
- HER-2 Positive Breast CancerMr. Cordero-Sampayo isAdvanced. Learn about HER-2 Positive Breast Cancer.
- Mucopolysaccharidoses (MPS)Mr. Cordero-Sampayo isAdvanced. Learn about Mucopolysaccharidoses (MPS).
- Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome)
- Experienced
- AgranulocytosisMr. Cordero-Sampayo isExperienced. Learn about Agranulocytosis.
- Febrile NeutropeniaMr. Cordero-Sampayo isExperienced. Learn about Febrile Neutropenia.
- Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome)Mr. Cordero-Sampayo isExperienced. Learn about Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome).